• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PET meets universal cancer screening

Article

Ever wonder what could be learned about the incidence of cancer if everyone was scanned?

Ever wonder what could be learned about the incidence of cancer if everyone was scanned?

This may be an outrageous question to pose in the U.S., but not so in Japan, where healthcare consumers have always been fascinated by the diagnostic possibilities of ad¬vanced imaging technology. The Japanese Ministry of Health, Labor, and Welfare is considering the possibility of universal cancer screening. Survey results from 92 PET and PET/CT imaging services identified verifiable results from 88,224 FDG-PET cancer screenings performed in 2005 and 2006.

By analyzing those cases, Dr. Ryogo Minaminoto and colleagues at four Japanese hospitals and clinics identified 922 cases of previously undetected cancer. The incidence rate was 1.04%. Colon/rectum, thyroid, lung, and breast cancers were the most common metastatic conditions uncovered by the screenings. The sensitivities of the imaging exams were 87%, 89%, 81%, and 88%, respectively.

Minaminoto concluded that the number of PET centers in Japan is growing steadily, highlighting the need to evaluate the usefulness of PET cancer screening.

Results were described in June in a scientific poster displayed at the 2008 SNM conference.

-By James Brice

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.